Please provide your email address to receive an email when new articles are posted on . More than 85% of patients with COPD receiving valaciclovir for 8 weeks suppressed the Epstein-Barr virus. No ...
The use of valaciclovir as prophylaxis prevents herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE) receiving anifrolumab treatment, with no cases of zoster reported during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results